BAJAJ BROKING

Notification close image
No new Notification messages
card image
Travel Food Services IPO is Open!
Apply for the Travel Food Services IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

18506

0

SAROJA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SAROJA PHARMA INDUS IND L performance

Today’s low

Today’s high

₹ 36.00 ₹ 36.00
₹ 36.00

52 week low

52 week high

₹ 34.00 ₹ 70.75
₹ 36.00

Open Price

₹ 36.00

Prev. Close

₹ 36.00

Volume (Shares)

3200.00

Total traded value

₹ 1.15

Upper Circuit

₹ 43.20

Lower Circuit

₹ 28.80

info

SAROJA PHARMA INDUS IND L Share Price Update

As of the latest trading session, SAROJA PHARMA INDUS IND L share price is currently at ₹ 36, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 36.00 and ₹ 36.00. Over the past year, SAROJA PHARMA INDUS IND L has achieved a return of -16.66 %. In the last month alone, the return has been -6.24 %. Read More...

Investment Returns

Over 1 Month -6.24% Over 3 Months -13.14% Over 6 Months -41.88% Over 1 Year -16.66%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SAROJA PHARMA INDUS IND L fundamentals


  • Market cap (Cr)

    14.50

  • P/E Ratio (TTM)

    14.01

  • Beta

    -0.07

  • Book Value / share

    39.00

  • Return on equity

    8.92%

  • EPS (TTM)

    2.57

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

info icon alternate text

SAROJA PHARMA INDUS IND L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 53.73
Operating Expense 52.45
Net Profit 1.03
Net Profit Margin (%) 1.91
Earnings Per Share (EPS) 2.57
EBITDA 2.96
Effective Tax Rate (%) 28.27
Particulars MAR 2024 (Values in Cr)
Revenue 40.67
Operating Expense 39.66
Net Profit 0.88
Net Profit Margin (%) 2.16
Earnings Per Share (EPS) 2.49
EBITDA 2.75
Effective Tax Rate (%) 27.27
Particulars MAR 2023 (Values in Cr)
Revenue 50.19
Operating Expense 48.86
Net Profit 1.06
Net Profit Margin (%) 2.11
Earnings Per Share (EPS) 3.61
EBITDA 2.88
Effective Tax Rate (%) 28.85
Particulars MAR 2022 (Values in Cr)
Revenue 55.63
Operating Expense 54.37
Net Profit 1.14
Net Profit Margin (%) 2.04
Earnings Per Share (EPS) 50.49
EBITDA 2.42
Effective Tax Rate (%) 27.84
Particulars MAR 2021 (Values in Cr)
Revenue 36.66
Operating Expense 35.71
Net Profit 0.73
Net Profit Margin (%) 1.99
Earnings Per Share (EPS) 731.30
EBITDA 1.39
Effective Tax Rate (%) 28.84
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.42
ROE % 8.92
ROCE % 14.92
Total Debt to Total Equity 0.81
EBITDA Margin 6.76
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.33
ROE % 23.25
ROCE % 22.08
Total Debt to Total Equity 1.79
EBITDA Margin 5.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 178.30
ROE % 45.88
ROCE % 33.69
Total Debt to Total Equity 1.84
EBITDA Margin 4.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 935.90
ROE % 77.66
ROCE % 34.34
Total Debt to Total Equity 3.21
EBITDA Margin 3.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.32
Total Assets 26.56
Total Liabilities 26.56
Total Equity 14.64
Share Outstanding 4020486
Price to Book Ratio 0.96
Return on Assets (%) 3.30
Return on Capital (%) 4.31
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 21.33
Total Liabilities 21.33
Total Equity 5.08
Share Outstanding 2935686
Price to Book Ratio 0.00
Return on Assets (%) 4.97
Return on Capital (%) 6.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.26
Total Assets 15.51
Total Liabilities 15.51
Total Equity 4.02
Share Outstanding 225822
Price to Book Ratio 0.00
Return on Assets (%) 7.34
Return on Capital (%) 11.22
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 8.22
Total Liabilities 8.22
Total Equity 0.93
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 8.89
Return on Capital (%) 18.5
Particulars MAR 2024 (Values in Cr)
Net Income 1.20
Cash from Operations 1.35
Cash from Investing -4.76
Cash from Financing 3.69
Net change in Cash -0.04
Free Cash Flow 1.74
Particulars MAR 2023 (Values in Cr)
Net Income 1.49
Cash from Operations 2.61
Cash from Investing -4.82
Cash from Financing 2.73
Net change in Cash 0.09
Free Cash Flow 6.34
Particulars MAR 2022 (Values in Cr)
Net Income 1.57
Cash from Operations -3.23
Cash from Investing -0.33
Cash from Financing 4.26
Net change in Cash 0.26
Free Cash Flow -2.93
Particulars MAR 2021 (Values in Cr)
Net Income 1.03
Cash from Operations -0.74
Cash from Investing -0.05
Cash from Financing 1.02
Net change in Cash -0.07
Free Cash Flow -0.69
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 7624.00 46.05 4.00 22446.39 4882.00 / 8165.25
BASF INDIA LTD 5166.30 48.81 6.15 22362.66 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 365.75 35.86 1.85 1230.88 252.40 / 656.00
DEEPAK FERTILIZERS & PETR 1598.00 21.61 3.23 20172.80 726.60 / 1776.95
DEEPAK NITRITE LTD 1980.40 38.74 5.01 27011.28 1780.50 / 3168.65
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 186.90 55.63 4.26 16.82 171.00 / 330.00
ATUL LTD 7624.00 48.90 4.05 22446.39 4882.00 / 8165.25
BASF INDIA LTD 5166.30 47.31 6.11 22362.66 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 365.75 26.28 1.81 1230.88 252.40 / 656.00

SAROJA PHARMA INDUS IND L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
36.00 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 36.30
  • 26 Days 39.20
  • 10 Days 37.20
  • 50 Days 41.80
  • 12 Days 37.50
  • 100 Days 45.10
  • 20 Days 38.60
  • 200 Days 48.10
35.33 PIVOT

First Support

34.67

First Resistance

36.67

Second Support

33.33

Second Resistance

37.33

Third Support

32.67

Third Resistance

38.67

RSI

40.24

ADX

11.35

MACD

-1.75

Williams % R

-74.68

Commodity Channel Index (CCI)

-104.98

Date

2025-07-07

Week

3733.00

Same Day

1600.00

Month

6400.00

1 Year

-0.07

3 Year

0.27

Over 1 Month

-6.24%

down

Over 1 Year

-16.66%

down

Over 3 Months

-13.14%

down

Over 3 Years

0.00%

down

Over 6 Months

-41.88%

down

Over 5 Years

0.00%

down

SAROJA PHARMA INDUS IND L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
26.98%
Promoter Holdings
73.01%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Biju Gopinathan Nair 2896672.0 (72.05%) Shareholding of Promoter and Promoter Group
Swastika Investmart Ltd 76800.0 (1.91%) Public Shareholding
Pranay Dattatrey Raut 57600.0 (1.43%) Public Shareholding
Kamlesh Natwarlal Shah 52800.0 (1.31%) Public Shareholding
Manish Dasharath Kamble 39000.0 (0.97%) Shareholding of Promoter and Promoter Group
Pulinattu Damodaran Nandakumar 2.0 (0.0%) Shareholding of Promoter and Promoter Group
Aditri Biju Nair 2.0 (0.0%) Shareholding of Promoter and Promoter Group
Sushama Dasharath Kamble 2.0 (0.0%) Shareholding of Promoter and Promoter Group
Saroja Nair 2.0 (0.0%) Shareholding of Promoter and Promoter Group
Sonal Siddarth Diwadkar 2.0 (0.0%) Shareholding of Promoter and Promoter Group
Bindu Ramachandran Kurup 2.0 (0.0%) Shareholding of Promoter and Promoter Group
Rethi Krishnan Nair 2.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SAROJA PHARMA INDUS IND L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SAROJA PHARMA INDUS IND L Share Price

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra. Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023.

Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business.

In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.' During this time, they focused on building a strong foundation and laying the groundwork for their future growth and success. With dedication and strategic planning, they managed to establish a reputable presence in the pharmaceutical industry.

Gradually, as Company expanded and gained momentum, the Promoters made a significant decision to convert their business from a Private Limited to a Public Limited, through which the Company was establish. Thus, transformation opened up new avenues for growth, allowing it to access a wider pool of investors and enhance the overall market presence.

With the new status as a Public Limited Company, Saroja Pharma Industries India Limited further strengthen position into pharmaceutical and healthcare sectors. Thereafter, the Promoters envisioned leveraging the Company's expanded resources, increased capital formation, and enhanced market reach.

Under the leadership of Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, Company continues for excellence, innovation, and global integration. Their commitment in providing high-quality pharmaceutical and healthcare products has helped it earn recognition and trust from both domestic and international customers. With a customer-centric approach and a focus on industry-leading practices, Company is poised to make a significant impact in the global healthcare landscape.

Since established, the Company provide service deliverance in chemical trading with the best premium pharmaceutical companies in India and abroad for cost effective human and veterinary medicine. Presently, the Company trade into Active Pharmaceuticals Ingredients (API), Pharma Intermediates, Specialty Chemicals, Intermediates for Pharma trading and Solvents used for pharmaceutical products in human and veterinary medicine.

The product demand by their clientele is manufactured as per their specifications by suppliers initially in sample size thereafter on clients testing and approving the order is finalized. The approved specified product is manufactured for the order quantity to be dispatched by the appropriate mode of transport within India or abroad. Prior to this, the Company witnessed a substantial expansion in its clientele base over the past two years. This growth has propelled the Company to venture into the manufacturing of API Pharma products, in making cost-effective contributions to human and veterinary medicine.

The Company is planning for a Public Issue of 10,84,800 Equity shares aggregating to Rs 9.11 Crores by raising capital through Fresh Issue.

Parent organization Indian Private
NSE symbol SAROJA
Founded 2019
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Saroja Pharma Industries India Ltd?

Answer Field

Saroja Pharma Industries India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 07 2025 12:00 AM.

What is the Market Cap of Saroja Pharma Industries India Ltd Share?

Answer Field

The market cap of Saroja Pharma Industries India Ltd for NSE ₹ 14.50 & for BSE ₹ 0.00 as on Jul 07 2025 12:00 AM.

What is the 52 Week High and Low of Saroja Pharma Industries India Ltd?

Answer Field

The 52 Week High and Low of Saroja Pharma Industries India Ltd for NSE is ₹ 70.75 and ₹ 34.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Saroja Pharma Industries India Ltd?

Answer Field

The 1 year returns on the stock has been -16.66%.

What is the P/E Ratio of Saroja Pharma Industries India Ltd Share?

Answer Field

As on Jul 07 2025 12:00 AM the price-to-earnings (PE) ratio for Saroja Pharma Industries India Ltd share is 14.01.

What is the PB ratio of Saroja Pharma Industries India Ltd Share?

Answer Field

As on Jul 07 2025 12:00 AM, the price-to-book (PB) ratio for Saroja Pharma Industries India Ltd share is 39.00.

How to Buy Saroja Pharma Industries India Ltd Share?

Answer Field

You can trade in Saroja Pharma Industries India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Saroja Pharma Industries India Ltd Share on Bajaj Broking App?

Answer Field

To buy Saroja Pharma Industries India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Saroja Pharma Industries India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|